[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CRIS":3,"homepage-market-summary":29,"stock-stats-CRIS":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CRIS","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Curis Inc","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.","24","Lexington, MA",false,{"close":16,"open":17,"high":17,"low":16,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},0.8034,0.8388,0.8307,-0.0273,-3.29,99482.291688,466,0.8167,6.74,0.18000001,1019435.363860804,9.5,6581,{"status":30,"indices":31,"watchlist":75,"sectors":97,"benchmarks":153},"success",[32,40,47,54,61,68],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":59,"is_up":38,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":38,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":14,"sparkline":74,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":38,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":38,"sparkline":89,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":38,"sparkline":96,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[98,103,108,113,118,123,128,133,138,143,148],{"name":99,"etf":100,"change":101,"price":102,"is_up":38},"Technology","XLK",1.01,199.81,{"name":104,"etf":105,"change":106,"price":107,"is_up":38},"Financials","XLF",0.06,53.49,{"name":109,"etf":110,"change":111,"price":112,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":114,"etf":115,"change":116,"price":117,"is_up":38},"Consumer Cycl","XLY",1.13,110.04,{"name":119,"etf":120,"change":121,"price":122,"is_up":38},"Consumer Staples","XLP",0.25,80.53,{"name":124,"etf":125,"change":126,"price":127,"is_up":38},"Energy","XLE",0.4,62.95,{"name":129,"etf":130,"change":131,"price":132,"is_up":38},"Industrials","XLI",0.78,169.95,{"name":134,"etf":135,"change":136,"price":137,"is_up":38},"Materials","XLB",0.66,48.86,{"name":139,"etf":140,"change":141,"price":142,"is_up":38},"Real Estate","XLRE",0.32,40.81,{"name":144,"etf":145,"change":146,"price":147,"is_up":38},"Utilities","XLU",0.38,39.83,{"name":149,"etf":150,"change":151,"price":152,"is_up":38},"Comm Services","XLC",0.35,110.32,[154,159,163,167],{"ticker":155,"name":156,"price":157,"change":158,"is_up":38},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":160,"name":161,"price":162,"change":88,"is_up":38},"QQQ","Invesco QQQ Trust",749.58,{"ticker":164,"name":165,"price":166,"change":52,"is_up":38},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":168,"name":169,"price":170,"change":66,"is_up":38},"IWM","iShares Russell 2000",281.52,{"ticker":4,"company_name":7,"current_price":16,"data_notice":172,"valuation":173,"dates":177,"share_statistics":180,"valuation_ratios":183,"enterprise_valuation":185,"financial_position":190,"financial_efficiency":195,"taxes":200,"price_statistics":201,"income_statement":208,"balance_sheet":215,"cash_flow":222,"margins":226,"dividends":227,"analyst_forecast":230,"fair_value":232,"splits":234},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":174,"enterprise_value":175,"summary":176},1948307.6652,1933414.67,"CRIS has a market cap of $1,948,307.67. Enterprise value is $1,933,414.67.",{"latest_fiscal_period_end":178,"earnings_date":9,"ex_dividend_date":9,"summary":179},"2026-03-31","Most recent reported fiscal period end: 2026-03-31.",{"shares_outstanding":181,"owned_by_insiders":9,"owned_by_institutions":9,"summary":182},2090077,"CRIS has 2,090,077 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":184,"pfcf_ratio":9,"pocf_ratio":9},80.34,{"ev_earnings":186,"ev_sales":9,"ev_ebitda":187,"ev_ebit":188,"ev_fcf":189},-79.9,1551.7,-167.85,-214.8,{"current_ratio":191,"debt_equity":192,"debt_ebitda":193,"debt_fcf":111,"summary":194},1.11,0.01,0.09,"The company has a current ratio of 1.11.",{"roe":196,"roa":197,"revenue_per_employee":9,"profit_per_employee":198,"employee_count":199,"asset_turnover":9},-190.44,-81.52,-1008,24,{"income_tax":9},{"beta_5y":9,"price_change_52w":202,"ma_50":203,"ma_200":204,"rsi_14":205,"avg_volume_20d":206,"summary":207},-50.1,2.11,1.38,11.43,154783,"The stock price has changed by -50.10% in the last 52 weeks.",{"revenue":9,"gross_profit":209,"operating_income":210,"pretax_income":211,"net_income":211,"ebitda":212,"ebit":210,"eps":213,"summary":214},0,-11519,-24199,1246,-25,"Income statement data is not available for this symbol.",{"cash_and_equiv":216,"total_debt":217,"net_cash":218,"net_cash_per_share":192,"equity_book_value":219,"book_value_per_share":192,"working_capital":220,"summary":221},15001,108,14893,12707,1637,"The company reported $15,001.00 in cash and $108.00 in debt.",{"operating_cash_flow":223,"capital_expenditures":9,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":224,"fcf_per_share":-6,"summary":225},-22153,-9001,"Free cash flow was $-9,001.00.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":228,"summary":229},-0.46,"CRIS has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":231},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":233},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":235},"Stock split history is not available for this symbol."]